个人简介
Dr. Thomas K. H. Chang completed a bachelor of science and a doctor of philosophy in pharmaceutical sciences at UBC. He pursued his postdoctoral studies in the Division of Cancer Pharmacology at the Dana-Farber Cancer Institute and the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. Dr. Chang also completed the faculty certificate program on Teaching and Learning in Higher Education at UBC.
Currently, Dr. Chang is Professor and Associate Dean, Graduate and Postdoctoral Studies and a UBC Distinguished University Scholar.
研究领域
Nuclear receptors are evolutionarily-related DNA-binding transcription factors that regulate the expression of a broad array of genes involved in various biological processes. There are 48 known members in the superfamily of nuclear receptors in the human genome. Of particular interest to Dr. Chang’s laboratory are nuclear receptors that govern the actions of genes (e.g. transporters such as P-glycoprotein and drug-metabolizing enzymes such as cytochromes P450), and regulate the transport, bioactivation and detoxification of xenobiotics (e.g. drugs, environmental chemicals) and endogenous substances (e.g. steroid hormones, vitamins, bile acids). These nuclear receptors include constitutive androstane receptor (CAR) and pregnane X receptor (PXR). The overall goal of Dr. Chang’s research program is to enhance our understanding of the molecular and cellular determinants that regulate the transport, bioactivation and detoxification of drugs, and how they affect inter-individual differences in drug action. Dr. Chang’s research program is supported by the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research.
Chemical Biology and Pharmacology of Nuclear Receptors
Nuclear receptors such as constitutive androstane receptor and pregnane X receptor are potential therapeutic targets for various human diseases. Thus, it is important to identify chemical modulators of these receptors. Studies are underway that focus on natural products and synthetic drugs. This will pave the way for future drug development efforts to find selective, potent and effective modulators. Other studies include elucidating the cellular and molecular mechanisms by which drugs and other chemicals activate constitutive androstane receptor and pregnane X receptor, and identifying the various factors that regulate the expression and function of these nuclear receptors.
Functional Analysis of Splice Variants of Nuclear Receptors
Alternative splicing of a gene results in the formation of multiple protein isoforms with varying amino acid sequence. The splice variants may have different regulation, function and tissue distribution when compared with the wild-type isoform. There are many splice variants of the human constitutive androstane receptor, several of which are expressed predominantly in the liver. Various studies are ongoing to investigate the functionality of naturally occurring splice variants of the human constitutive androstane receptor (e.g. hCAR-SV23, hCAR-SV24).
近期论文
查看导师最新文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Differential activation of human constitutive androstane receptor and its SV23 and SV24 splice variants by rilpivirine and etravirine, Sharma, Devinder, Lau Aik Jiang, Sherman Matthew A., and Chang Thomas K. H. , British Journal of Pharmacology, Jan-03-2015, Volume 172, Issue 5, p.1263 - 1276, (2015)
Fetal bovine serum and human constitutive androstane receptor: Evidence for activation of the SV23 splice variant by artemisinin, artemether, and arteether in a serum-free cell culture system, Lau, Aik Jiang, and Chang Thomas K. H. , Toxicology and Applied Pharmacology, Jan-06-2014, Volume 277, Issue 2, p.221 - 230, (2014)
Agonism of human pregnane X receptor by rilpivirine and etravirine: Comparison with first generation non-nucleoside reverse transcriptase inhibitors, Sharma, Devinder, Lau Aik Jiang, Sherman Matthew A., and Chang Thomas K. H. , Biochemical Pharmacology, Jan-06-2013, Volume 85, Issue 11, p.1700 - 1711, (2013)
Indirect activation of the SV23 and SV24 splice variants of human constitutive androstane receptor: analysis with 3-hydroxyflavone and its analogues, Lau, Aik Jiang, and Chang Thomas K. H. , British Journal of Pharmacology, Jan-09-2013, Volume 170, Issue 2, p.403 - 414, (2013)
Isoform-Selective Activation of Human Constitutive Androstane Receptor by Ginkgo biloba Extract: Functional Analysis of the SV23, SV24, and SV25 Splice Variants, Lau, A. J., Yang G., and Chang T. K. H. , Journal of Pharmacology and Experimental Therapeutics, Jan-11-2011, Volume 339, Issue 2, p.704 - 715, (2011)